Peter Maccallum Cancer Centre
Bendigo, Victoria, Australia
Radiologist in Bendigo, Victoria
100 Barnard St, Bendigo VIC 3550
About Peter Maccallum Cancer Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Peter Maccallum Cancer Centre
During the past decade, Peter Maccallum Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
2002-03-01
2004-01-01
Completed
210
Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker
2002-09-01
Terminated
75
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
2000-04-27
2003-11-07
Completed
2,532
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
2005-03-01
2007-05-01
Completed
500
Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
2003-04-01
2004-06-01
Completed
529
Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
2006-08-01
2007-12-01
Completed
189
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Peter Maccallum Cancer Centre"
#1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Canadian Breast Cancer Research Alliance" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Peter Maccallum Cancer Centre
According to Clinical.Site data, the most researched conditions in "Peter Maccallum Cancer Centre" are
"Adenocarcinoma of Rectum" (1 trials), "Breast Cancer" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Peter Maccallum Cancer Centre" in a lesser frequency.
Clinical Trials Intervention Types at Peter Maccallum Cancer Centre
Most popular intervention types in "Peter Maccallum Cancer Centre" are "Radiation" (4 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "APBI utilizing 3D-CRT radiation" (1 trials), "Concurrent Chemotherapy" (1 trials), "Conventional NSAA" (1 trials), "Conventionally Fractionated Radiotherapy (ConRT)" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Peter Maccallum Cancer Centre
The vast majority of trials in "Peter Maccallum Cancer Centre" are
2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Peter Maccallum Cancer Centre
Currently, there are NaN active trials in "Peter Maccallum Cancer Centre".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Peter Maccallum Cancer Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Peter Maccallum Cancer Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".